sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> respiratory disease market

report

Respiratory Disease Market, by Diseases (Pulmonary Hypertension, Cystic Fibrosis, Asthma, And Chronic Obstructive Pulmonary Disease) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC141 October 2016 100+ FREE 10% CUSTOMIZATION

The global respiratory disease market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges in the respiratory disease market.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The market for the respiratory medicines & drugs has already proven profitable for the pharmaceutical manufacturers and marketers.  Many blockbuster brands and steady annual sales have increased the size of the respiratory disease market.
  • The pharmaceutical manufacturers have received substantial success in the treatment of the common respiratory diseases such as asthma, chronic obstructive pulmonary diseases, and respiratory allergies.
  • The respiratory disease market is majorly driven by the increasing incidences of chronic respiratory disorders, coupled with the rising demand for the respiratory therapeutics.
  • The incidences of respiratory disorders, such as chronic obstructive pulmonary disease, asthma, respiratory allergies, and others are expected to increase in the near future as stated by many governments and organizations, including the World Health Organization (WHO).  This fact would, in turn, have increased the interest of many manufacturers in increasing the investments in developing the respiratory-related therapeutics.
  • The companies such as GlaxoSmithKline, F. Hoffman-La Roche, Novartis, and Merck & Co., are continuously increasing their research and development expenses to develop novel respiratory diseases drugs, leading to a strong drive in the respiratory disease market.
  • However, the availability of the alternative treatment therapies for respiratory disorders will hamper the market growth to some extent, during the future period.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s respiratory disease market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the respiratory disease market by the following segments:

Respiratory Diseases Market, by Diseases

  • Pulmonary hypertension
  • Cystic Fibrosis
  • Asthma and Chronic Obstructive Pulmonary Disease (COPD)
  • Others

KEY MARKET PLAYERS

Key players in the respiratory disease market include:

  • AstraZeneca
  • Boehringer Ingelheim GmBh
  • F. Hoffmann-La Roche
  • GlaxoSmithKline Plc
  • Forest Laboratories, Inc.
  • Merck & Co., Inc.
  • Novartis AG.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Respiratory Disease Market

TRENDING RELATED REPORT

Molecular Diagnostics Market, by Products (Instruments & Systems and Reagents & Consumables), Applications (Infectious Diseases, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Genetic Testing and Pharmacogenomics), Technologies (DNA Sequencing, PCR Microarray and Fluorescent In Situ Hybridization) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
    4. Assumptions
    5. Limitations
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
    3. Regulatory Issues
    4. Patent Analysis
  5. RESPIRATORY DISEASES MARKET, BY DISEASES
    1. Segment Share
    2. By Diseases
      1. Pulmonary Hypertension
      2. Cystic Fibrosis
      3. Asthma and Chronic Obstructive Pulmonary Disease
      4. Others
  6. RESPIRATORY DISEASES MARKET, BY DISEASES
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Diseases
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Diseases
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Diseases
    4. Middle East & Africa
      1. By Country
        1. GCC
        2. North Africa
        3. South Africa
        4. Rest of Middle East & Africa
      2. By Diseases
    5. Latin America
      1. By Country
        1. Brazil
        2. Rest of Latin America
      2. By Diseases
  7. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovator Companies
  8. KEY MARKET PLAYERS
    1. Astrazeneca
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Boehringer Ingelheim GmbH
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. F. Hoffman-La Roche Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. GlaxoSmithKline Plc
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Forest Laboratories, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Merck & Co., Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Novartis AG
      1. Overview
      2. Key Strategies
      3. Key Developments
  9. SCALAR 360 DEGREE MARKET PERSPECTIVE
  10. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us